Asset profile
Pulmatrix Inc is a biopharmaceutical company focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, …
Nothing scheduled in this window.
Newest first.
| Registry ID | Phase | Status | Primary completion | Enrollment | Sites |
|---|---|---|---|---|---|
| NCT03960606 | Phase 2 | Terminated | Jul 14, 2020 | 7 | 9 of 20 sites in the United States |